Related Articles
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma
Clinical significance of coagulation factors in operable colorectal cancer
Paclitaxel in anthracycline-treated breast cancer patients.